MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/brain/awab252

Медицинская библиотека · Brain : a journal of neurology · 2022

Transcranial alternating current stimulation for treating depression: a randomized controlled trial.

Wang Hongxing, Wang Kun, Xue Qing, Peng Mao, Yin Lu, Gu Xuecun, Leng Haixia, Lu Juan, Liu Hongzhi, Wang Di, Xiao Jin, Sun Zhichao, Li Ning, Dong Kai, Zhang Qian, Zhan Shuqin, Fan Chunqiu, Min Baoquan, Zhou Aihong, Xie Yunyan, Song Haiqing, Ye Jing, Liu Aihua, Gao Ran, Huang Liyuan, Jiao Lidong, Song Yang, Dong Huiqing, Tian Zichen, Si Tianmei, Zhang Xiangyang, Li Xinmin, Kamiya Atsushi, Cosci Fiammetta, Gao Keming, Wang Yuping

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Treatment of depression with antidepressants is partly effective. Transcranial alternating current stimulation can provide a non-pharmacological alternative for adult patients with major depressive disorder. However, no study has used the stimulation to treat first-episode and drug-naïve patients with major depressive disorder. We used a randomized, double-blind, sham-controlled design to examine the clinical efficacy and safety of the stimulation in treating first-episode drug-naïve patients in a Chinese Han population. From 4 June 2018 to 30 December 2019, 100 patients were recruited and randomly assigned to receive 20 daily 40-min, 77.5 Hz, 15 mA, one forehead and two mastoid sessions of active or sham stimulation (n = 50 for each group) in four consecutive weeks (Week 4), and were followed for additional 4-week efficacy/safety assessment without stimulation (Week 8). The primary outcome was a remission rate defined as the 17-item Hamilton Depression Rating Scale (HDRS-17) score ≤ 7 at Week 8. Secondary analyses were response rates (defined as a reduction of ≥ 50% in the HDRS-17), changes in depressive symptoms and severity from baseline to Week 4 and Week 8, and rates of adverse events. Data were analysed in an intention-to-treat sample. Forty-nine in the active and 46 in the sham completed the study. Twenty-seven of 50 (54%) in the active treatment group and 9 of 50 (18%) in the sham group achieved remission at the end of Week 8. The remission rate was significantly higher in the active group compared to that in the sham group with a risk ratio of 1.78 (95% confidence interval, 1.29, 2.47). Compared with the sham, the active group had a significantly higher remission rate at Week 4, response rates at Weeks 4 and 8, and a larger reduction in depressive symptoms from baseline to Weeks 4 and 8. Adverse events were similar between the groups. In conclusion, the stimulation on the frontal cortex and two mastoids significantly improved symptoms in first-episode drug-naïve patients with major depressive disorder and may be considered as a non-pharmacological intervention for them in an outpatient setting.

Для цитирования: Wang Hongxing, Wang Kun, Xue Qing, Peng Mao, Yin Lu, Gu Xuecun, Leng Haixia, Lu Juan, Liu Hongzhi, Wang Di, Xiao Jin, Sun Zhichao, Li Ning, Dong Kai, Zhang Qian, Zhan Shuqin, Fan Chunqiu, Min Baoquan, Zhou Aihong, Xie Yunyan, Song Haiqing, Ye Jing, Liu Aihua, Gao Ran, Huang Liyuan, Jiao Lidong, Song Yang, Dong Huiqing, Tian Zichen, Si Tianmei, Zhang Xiangyang, Li Xinmin, Kamiya Atsushi, Cosci Fiammetta, Gao Keming, Wang Yuping. Transcranial alternating current stimulation for treating depression: a randomized controlled trial.. Brain : a journal of neurology. 2022. DOI: 10.1093/brain/awab252.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.